Janus Henderson Group PLC Sells 856 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Janus Henderson Group PLC decreased its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 0.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 2,410,782 shares of the medical instruments supplier’s stock after selling 856 shares during the period. Janus Henderson Group PLC owned about 0.10% of ICU Medical worth $374,080,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Gotham Asset Management LLC lifted its position in ICU Medical by 22.3% during the fourth quarter. Gotham Asset Management LLC now owns 40,610 shares of the medical instruments supplier’s stock valued at $6,301,000 after purchasing an additional 7,410 shares during the last quarter. FORA Capital LLC bought a new position in ICU Medical during the fourth quarter valued at $488,000. Deutsche Bank AG lifted its position in ICU Medical by 41.1% during the fourth quarter. Deutsche Bank AG now owns 21,792 shares of the medical instruments supplier’s stock valued at $3,381,000 after purchasing an additional 6,345 shares during the last quarter. Algert Global LLC lifted its position in ICU Medical by 16.9% during the fourth quarter. Algert Global LLC now owns 6,370 shares of the medical instruments supplier’s stock valued at $988,000 after purchasing an additional 920 shares during the last quarter. Finally, Freestone Grove Partners LP bought a new position in ICU Medical during the fourth quarter valued at $368,000. Institutional investors own 96.10% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have commented on ICUI shares. Raymond James lowered their price objective on shares of ICU Medical from $197.00 to $187.00 and set a “strong-buy” rating for the company in a research report on Friday. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Tuesday, April 8th. KeyCorp lowered their price objective on shares of ICU Medical from $209.00 to $191.00 and set an “overweight” rating for the company in a research report on Monday, April 21st. Finally, StockNews.com lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Saturday. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $192.67.

ICU Medical Trading Down 3.2%

Shares of ICUI opened at $138.30 on Monday. ICU Medical, Inc. has a twelve month low of $100.91 and a twelve month high of $196.26. The company has a market cap of $3.40 billion, a P/E ratio of -30.26 and a beta of 0.87. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The company’s fifty day simple moving average is $140.67 and its 200-day simple moving average is $154.99.

ICU Medical (NASDAQ:ICUI) last announced its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.49. ICU Medical had a negative net margin of 4.74% and a positive return on equity of 5.05%. The business had revenue of $599.49 million for the quarter, compared to the consensus estimate of $574.15 million. During the same quarter in the prior year, the firm posted $0.96 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. As a group, analysts expect that ICU Medical, Inc. will post 4.11 EPS for the current year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.